Form 8-K - Current report:
SEC Accession No. 0001104659-13-078850
Filing Date
2013-10-30
Accepted
2013-10-29 19:35:01
Documents
3
Period of Report
2013-10-26
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a13-23004_18k.htm 8-K 25747
2 EX-99.1 a13-23004_1ex99d1.htm EX-99.1 35806
3 GRAPHIC g230041mmi001.jpg GRAPHIC 4482
  Complete submission text file 0001104659-13-078850.txt   68803
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Filer) CIK: 0001157601 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33277 | Film No.: 131177503
SIC: 2834 Pharmaceutical Preparations